It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The blood–cerebrospinal fluid barrier (BCSFB) is a highly dynamic transport interface that serves brain homeostasis. To date, however, understanding of its role in brain development and pathology has been hindered by the absence of a non-invasive technique for functional assessment. Here we describe a method for non-invasive measurement of BSCFB function by using tracer-free MRI to quantify rates of water delivery from arterial blood to ventricular cerebrospinal fluid. Using this method, we record a 36% decrease in BCSFB function in aged mice, compared to a 13% decrease in parenchymal blood flow, itself a leading candidate biomarker of early neurodegenerative processes. We then apply the method to explore the relationship between BCSFB function and ventricular morphology. Finally, we provide proof of application to the human brain. Our findings position the BCSFB as a promising new diagnostic and therapeutic target, the function of which can now be safely quantified using non-invasive MRI.
The blood–cerebrospinal fluid barrier (BCSFB) is an important interface for brain homeostasis. Here the authors describe a non-invasive MRI technique for the quantitative assessment of BCSFB function.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 University College London, UCL Centre for Advanced Biomedical Imaging, Division of Medicine, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
2 University College London Hospitals NHS Foundation Trust, Medical Physics and Biomedical Engineering, London, UK (GRID:grid.52996.31) (ISNI:0000 0000 8937 2257)
3 University College London Cancer Institute, Pathology Core Facility, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
4 UCL Queen Square Institute of Neurology, Neuroradiological Academic Unit, Department of Brain Repair and Rehabilitation, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); UCL Queen Square Institute of Neurology, Leonard Wolfson Experimental Neurology Centre, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)